name  
bbb
 
       
   
Epicenttre Creative Karma ADL NeuroTech Friends Trust Mentamove l Swayamkrithi l Donations li Careers li Media li li Consultation
   
   
 
news
   
 

GLOBAL CAMPAIGN AGAINST EPILEPSY
Bringing
EPILEPSY
Out of the Shadows

Specific objectives of the Global campaign against epilepsy

  • reduce the treatment gap and the physical and social morbidity of people suffering from epilepsy through intervention at community level

  • train and educate health professionals;

  • dispel stigma and promote a positive attitude to people with epilepsy in the community;

  • identify and assess the potential for prevention of epilepsy;

  • develop a model for promotion of epilepsy control worldwide and for its integration in the health systems of participating countries

  • Management of Epilepsy

  • Drugs are the mainstay of treatment in epilepsy

  • In recent times epilepsy can also be treated by surgery

  • In addition to this life style modifications are important in the management of epilepsy

  • Attitude/Compliance

  • Confirmation of epilepsy
  • Objectives of treatment are to control seizures with minimum side effects

  • To enable this the first step is to confirm whether the fit, faint or fall is indeed due to epilepsy.

  • Classification by the ILAE classification is mandatory prior to starting treatment

  • All fits, faints & falls may not be epilepsy.

  • Cardiac disorders like aortic and mitral stenosis, Stokes Adams attacks, cardiac arrhythmias may cause syncopal attacks.

  • Beware of pseudoseizures

  • To treat or not to treat
  • Once a diagnosis of epilepsy is made, the question of whether to treat or not arises.

  • Recurrence rates after a single seizure (GTCS) vary from 16-61%.

  • After two tonic clonic seizures, the risk of having a third seizure rises to about 85%..

  • Risk factors for seizure recurrence
  • prior brain injury

  • abnormal neurological examination

  • epileptiform abnormalities on the EEG

  • occurrence of postictal or Todd paralysis

  • status epilepticus

  • a family h/o seizures

  • and acute symptomatic seizures caused by head trauma.

  • Classification
  • generalized

  • simple partial

  • complex partial

  • an epileptic syndrome

  • localisation related epilepsy

  • nonepileptic attack disorder

  • Seizure classification
  • Choice of drug according to seizure type is based on

  • the mechanism of action of the drug

  • traditionally established efficacy of some drugs in certain types of seizures.
  • Monotherapy vs Polytherapy

  • Having decided what drug to use, monotherapy with the first line drugs is preferred in most patients.

  • Polytherapy may have to resorted to in some patients

  • Drugs should be appropriately combined, taking into account drug interactions, side effects, mechanism of action,etc as rational polytherapy

  • Advantages of monotherapy
  • Equal or superior efficacy to many two or three drug regimens

  • Reduced frequency of adverse effects

  • Lack of drug interactions between antiepileptic drugs

  • Increased ability to correlate drug response, adverse effects, and laboratory values to a specific drug

  • Reduced risk of birth defects when used in women of child bearing age

  • Improved compliance – this is important as noncompliance is the most common cause of drug failure and breakthrough seizures

  • Age & Sex of the patient
  • The same drugs are used to treat both children and adults, but the pharmacokinetics and side effect profiles of the drugs can differ.

  • Many drugs such as phenytoin, need to be given in proportionately higher doses to achieve therapeutic levels in young children.

  • Also, drugs that cause one type of side effect in adults (sedation) may cause opposite effects (hyperactivity) in children.
  • Age & Sex + Other factors influencing drug choice

  • Phenytoin affects calcium metabolism and can interfere with growth, hence would not be a first choice in a young children.

  • In the elderly, one has to be alert to drug interactions between antiepileptic drugs and co medications such patients may often be taking for other illnesses.

  • In women, the teratogenic potential of a drug may influence the choice of drug.

  • Another precaution is to choose relatively nonsedating drugs in patients handling machinery, etc

  • Drug related factors
  • The mechanism of action of an AED

  • its plasma half life

  • the range between peak and trough blood therapeutic levels can influence the daily level and timing of dose of the drug

  • interactions during polytherapy

  • potential for teratogenicity, etc
  • Mechanisms of actions of anticonvulsants

  • Sodium pump – Phenytoin +++/ Carbamazepine +++/Phenobarbitone++/Valproate++

  • Calcium ion – Valproate +/ Ethosuximide +++

  • When sodium dependant ion channels are dampened, sustained high frequency neuronal firing is reduced and calcium uptake and excitatory neurotransmitter release is decreased

  • Some drugs directly facilitate GABA eg Benzodiazepines, Phenobarbitone, Valproate

  • Ethosuximide reduces slow rhythmic firing of thalamic neurons

  • The ultimate effect is to enhance the inhibitory GABA or reduce the excitatory glutamate

  •